» Articles » PMID: 18619997

Intrinsic Disorder in Scaffold Proteins: Getting More from Less

Overview
Date 2008 Jul 16
PMID 18619997
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

Regulation, recognition and cell signaling involve the coordinated actions of many players. Signaling scaffolds, with their ability to bring together proteins belonging to common and/or interlinked pathways, play crucial roles in orchestrating numerous events by coordinating specific interactions among signaling proteins. This review examines the roles of intrinsic disorder (ID) in signaling scaffold protein function. Several well-characterized scaffold proteins with structurally and functionally characterized ID regions are used here to illustrate the importance of ID for scaffolding function. These examples include scaffolds that are mostly disordered, only partially disordered or those in which the ID resides in a scaffold partner. Specific scaffolds discussed include RNase, voltage-activated potassium channels, axin, BRCA1, GSK-3beta, p53, Ste5, titin, Fus3, BRCA1, MAP2, D-AKAP2 and AKAP250. Among the mechanisms discussed are: molecular recognition features, fly-casting, ease of encounter complex formation, structural isolation of partners, modulation of interactions between bound partners, masking of intramolecular interaction sites, maximized interaction surface per residue, toleration of high evolutionary rates, binding site overlap, allosteric modification, palindromic binding, reduced constraints for alternative splicing, efficient regulation via posttranslational modification, efficient regulation via rapid degradation, protection of normally solvent-exposed sites, enhancing the plasticity of interaction and molecular crowding. We conclude that ID can enhance scaffold function by a diverse array of mechanisms. In other words, scaffold proteins utilize several ID-facilitated mechanisms to enhance function, and by doing so, get more functionality from less structure.

Citing Articles

Bipartite binding of the intrinsically disordered scaffold protein JIP1 to the kinase JNK1.

Orand T, Delaforge E, Lee A, Kragelj J, Tengo M, Tengo L Proc Natl Acad Sci U S A. 2025; 122(9):e2419915122.

PMID: 39999166 PMC: 11892650. DOI: 10.1073/pnas.2419915122.


Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression.

Sergeeva S, Loshchenova P, Oshchepkov D, Orishchenko K Int J Mol Sci. 2024; 25(19).

PMID: 39408734 PMC: 11476898. DOI: 10.3390/ijms251910405.


Polarized localization of kinesin-1 and RIC-7 drives axonal mitochondria anterograde transport.

Wu Y, Ding C, Sharif B, Weinreb A, Swaim G, Hao H J Cell Biol. 2024; 223(5).

PMID: 38470363 PMC: 10932739. DOI: 10.1083/jcb.202305105.


Design of intrinsically disordered proteins that undergo phase transitions with lower critical solution temperatures.

Zeng X, Liu C, Fossat M, Ren P, Chilkoti A, Pappu R APL Mater. 2024; 9(2).

PMID: 38362050 PMC: 10868716. DOI: 10.1063/5.0037438.


Ischemia-reperfusion injury in human AC16 cardiomyocytes is modulated by AXIN1 depending on c-Myc regulation.

Li J, Wang H, Chen L, Zhong J, Wang J, Xiao J Ann Med Surg (Lond). 2023; 85(10):4844-4850.

PMID: 37811065 PMC: 10553099. DOI: 10.1097/MS9.0000000000001139.


References
1.
Zhang Y, Neo S, Wang X, Han J, Lin S . Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem. 1999; 274(49):35247-54. DOI: 10.1074/jbc.274.49.35247. View

2.
Mujtaba S, He Y, Zeng L, Yan S, Plotnikova O, Sachchidanand . Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell. 2004; 13(2):251-63. DOI: 10.1016/s1097-2765(03)00528-8. View

3.
Oldfield C, Meng J, Yang J, Yang M, Uversky V, Dunker A . Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics. 2008; 9 Suppl 1:S1. PMC: 2386051. DOI: 10.1186/1471-2164-9-S1-S1. View

4.
Huttley G, Easteal S, Southey M, Tesoriero A, Giles G, McCredie M . Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet. 2000; 25(4):410-3. DOI: 10.1038/78092. View

5.
Elion E, Qi M, Chen W . Signal transduction. Signaling specificity in yeast. Science. 2005; 307(5710):687-8. DOI: 10.1126/science.1109500. View